Compugen (CGEN) Net Margin (2009 - 2026)

Compugen (CGEN) reported Net Margin of 351.98% for Q1 2026, up 4029.0% on a YoY basis from 8.52% in Q1 2025, and up 317.7% sequentially from 84.26% in Q4 2025.

Compugen (CGEN) Net Margin (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 14 years of Net Margin data on file, last reported at 351.98% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 4029.0% year-over-year to 351.98%; the trailing twelve-month figure through Mar 2026 stood at 49.39% (up 6873.0% YoY), and the FY2025 full-year result was 48.57%, up 9965.0% from the prior year.
  • Net Margin climbed to 351.98% in Q1 2026, from 84.26% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 351.98% in Q1 2026 to a low of 1719.49% in Q2 2025.
  • A 5-year average of 151.7% and a median of 29.03% in 2023 frame the typical range for Net Margin.
  • Peak annual rise in Net Margin reached 50010 bps in 2025, while the deepest fall reached 147146 bps in 2025.
  • Tracing CGEN's Net Margin over 5 years: stood at 41.23% in 2022, then jumped by 170 bps to 29.03% in 2023, then tumbled by 1532 bps to 415.84% in 2024, then surged by 120 bps to 84.26% in 2025, then soared by 318 bps to 351.98% in 2026.
  • Business Quant data shows CGEN's Net Margin at 351.98% in Q1 2026, 84.26% in Q4 2025, and 364.83% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Compugen 221.26 Mn 129.51 Mn 352,000.00 351.98%

Historic Data

Download Data
DateValue
Mar 31, 2026 351.98%
Dec 31, 2025 84.26%
Sep 30, 2025 -364.83%
Jun 30, 2025 -1,719.49%
Mar 31, 2025 311.69%
Dec 31, 2024 -415.84%
Sep 30, 2024 60.03%
Jun 30, 2024 -248.03%
Mar 31, 2024 283.74%
Dec 31, 2023 29.03%
Dec 31, 2022 -41.23%
Dec 31, 2020 -428.15%
Sep 30, 2018 -39.88%
Dec 31, 2016 -16,022.64%
Sep 30, 2016 -11,115.71%
Jun 30, 2016 -1,333.06%
Mar 31, 2016 -9,538.71%
Dec 31, 2015 -5.68%
Sep 30, 2015 -2,944.10%
Jun 30, 2015 -3,052.91%